Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Hims & Hers Health Inc (NY: HIMS )

23.62 +0.20 (+0.85%)
Official Closing Price Updated: 7:00 PM EST, Nov 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health Inc

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Why HIMS & HERS HEALTH INC (NYSE:HIMS) qualifies as a high growth stock.
Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing? 
Via Chartmill
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
Via Benzinga
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
The company expects to enjoy many GLP-1 tailwinds in 2025. 
Via The Motley Fool
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
According to analysts, even after a 6% rally on the morning of the earnings announcement, Hims & Hers stock might still be a buy today. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Decoding Hims & Hers Health's Options Activity: What's the Big Picture?
Via Benzinga
Smart Money Is Betting Big In HIMS Options
Via Benzinga
A Look Into Hims & Hers Health Inc's Price Over Earnings
Via Benzinga
How Is The Market Feeling About Hims & Hers Health?
Via Benzinga
What's Going On With Hims & Hers Health Stock Tuesday?
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and raised its full-year revenue outlook. Here's what you need to know. 
Via Benzinga
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Palantir, Trump Media, Hims & Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
The U.S. stock market experienced a slight downturn on Monday, with the S&P 500 index dipping approximately 0.3%. The Dow Jones Industrial Average fell 0.6% to 41,794.60. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
This Is What Whales Are Betting On Hims & Hers Health
Via Benzinga
Decoding 6 Analyst Evaluations For Hims & Hers Health
Via Benzinga
In-Depth Examination Of 6 Analyst Recommendations For Hims & Hers Health
Via Benzinga
Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details
Hims & Hers Health reported its third-quarter results after Monday's closing bell. Here's a look at the details from the report. 
Via Benzinga
IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory
Hims stock jumped late Monday after the online pharmacy beat expectations. 
Via Investor's Business Daily
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
From Hims & Hers
Via Business Wire
What's Going On With Hims & Hers Health Stock Monday?
Hims & Hers Health will report third-quarter financial results after the market close on Monday. Analysts expect the company to report earnings of 4 cents per share and revenue of $382.2 million,... 
Via Benzinga
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
Hims & Hers Health shares are falling Thursday following an FDA update listing Novo Nordisk diabetes drug Ozempic and weight-loss drug Wegovy as available, signaling possible supply stability. Here's... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Could This Magnificent Pharma Stock 10x in the Next 5 Years?
Disrupting pharmacies is just the start for Hims & Hers. 
Via The Motley Fool
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
From Hims & Hers
Via Business Wire
Top 3 Stocks Institutions Are Buying Right Now
Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks. 
Via MarketBeat
Hims & Hers Stock Dropped: Here's What You Need to Know
The GLP-1 drama continues at Hims & Hers. 
Via The Motley Fool
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Via Benzinga
Exposures Product Safety
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
From Hims & Hers
Via Business Wire
Why Hims & Hers' Incredible Growth Will Continue
GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is. 
Via The Motley Fool
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
Hims & Hers has enjoyed a rally on an FDA decision regarding Eli Lilly's tirzepatide. 
Via Investor's Business Daily
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.